Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I

Abstract

Neurofibromatosis type I is a rare neurocutaneous syndrome resulting from loss-of-function mutations of <i>NF1</i>. The present study sought to determine a correlation between mutation regions on <i>NF1</i> and the risk of developing optic pathway glioma (OPG) in patients with neurofibromatosis type I. A total of 215 patients with neurofibromatosis type I, from our clinic or previously reported literature, were included in the study after applying strict inclusion and exclusion criteria. Of these, 100 patients with OPG were classified into the OPG group and 115 patients without OPG (aged ≥ 10 years) were assigned to the Non-OPG group. Correlation between different mutation regions and risk of OPG was analyzed. The mutation clustering in the 5' tertile of <i>NF1</i> was not significantly different between OPG and Non-OPG groups (<i>P</i> = 0.131). Interestingly, patients with mutations in the cysteine/serine-rich domain of <i>NF1</i> had a higher risk of developing OPG than patients with mutations in other regions [<i>P</i> = 0.019, adjusted odds ratio (OR) = 2.587, 95% confidence interval (CI) = 1.167-5.736], whereas those in the HEAT-like repeat region had a lower risk (<i>P</i> = 0.036, adjusted OR = 0.396, 95% CI = 0.166-0.942). This study confirms a new correlation between <i>NF1</i> genotype and OPG phenotype in patients with neurofibromatosis type I, and provides novel insights into molecular functions of neurofibromin.